Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pi Health

Request full access

Pi Health pioneers health tech and clinical research, revolutionizing global access to cutting-edge medicines and clinical trials

Cambridge, United StatesFounded 2023Health Tech & Medtech

About Pi Health

Pi Health operates as an oncology-focused health technology and clinical research organization, established in 2021 by co-founders Dr. Geoffrey Kim and Dr. Bobby Reddy. The company was initially incubated as a subsidiary of the global biotechnology company BeiGene before launching independently. In March 2024, Pi Health secured over $30 million in a Series A funding round led by AlleyCorp and Obvious Ventures, with participation from Invus Capital. This financing is intended to support the expansion of its global trial site partnerships and the further development of its core technology.

The founders bring extensive experience in oncology and regulatory affairs to the company. Dr. Geoffrey Kim, the CEO, has over 25 years of experience in oncology drug development and previously served as the Deputy Director of the Oncology Center of Excellence at the U.S. Food and Drug Administration (FDA), in addition to holding leadership roles at AstraZeneca and BeiGene. Dr. Bobby Reddy, the COO, also held leadership positions at BeiGene and AstraZeneca and is a practicing dermatologist at Massachusetts General Hospital. Their collective background in cancer treatment and clinical trial regulation directly informs the company's mission to address inefficiencies in the drug development process.

The company's business is centered on improving the clinical trial process for life sciences companies, specifically within oncology. Pi Health addresses the challenge of low patient participation in clinical studies, where fewer than 8% of eligible cancer patients enroll, by connecting pharmaceutical companies and trial sponsors with a diverse, global patient population. This is achieved through its proprietary software platform, FICS (Front-End Interoperable Capture Software), and a growing international network of clinical trial sites across the US, Brazil, Australia, and India. Revenue is generated by providing this integrated solution to life sciences companies to help them develop medicines faster and more cost-effectively.

The FICS platform is a comprehensive, AI-powered system designed to replace multiple, disconnected software solutions often used in clinical trials. It unifies capabilities for electronic data capture (EDC), clinical trial management (CTMS), and trial master file (TMF) management into a single interface. Key features include the automation of manual processes for data collection, the generation of regulatory-grade data from the outset, and tools to streamline communication between trial sites and sponsors. By using generative AI, the platform also assists with automating clinical documentation and matching patients to appropriate trials. A significant milestone was the opening of the Pi Health Cancer Hospital in Hyderabad, India, in 2023, which serves as a model site showcasing the platform's ability to manage clinical trial data and operations efficiently.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
65
Open positions
4
Dealroom signal
64.2/100
Industry
Health
Sub-industry
Health Platform
Technology
Artificial Intelligence
Business model
SaaS
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Apr 2026 $0 — Pi Holdings Corp ↗
SERIES A✓Equity / VC Mar 2024 $30M $120M Obvious Ventures · AlleyCorp · Invus ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Pi Health website traffic

Latest recorded traffic for Pi Health is 3.5K monthly website visits, up 169.2% over the last three months. Pi Health's team declined 4.4% over the past year.

Latest monthly visits3.5K 3-month web change+169.2% 1-year team growth-4.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Pi Health in the Cambridge ecosystem

Live from Dealroom

The Pi Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Other known investors1 additional known investor

  • Pi Holdings Corp
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇺🇸 United States78%
🇮🇳 India10%
🇬🇧 United Kingdom4%
🇧🇷 Brazil2%
🇨🇭 Switzerland2%
Top 5 of 7 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pi Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pi Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.